Combined Alternating Sunitinib and Bevacizumab (Avastin®) in Advanced Renal Cell Carcinoma (CASA)
Clinical trial NCT02919371 · UNKNOWN
Trial details
- NCT number
- NCT02919371
- Sponsor
- King Faisal Specialist Hospital & Research Center
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-01
- Primary completion
- 2020-12-01
- Enrollment
- 77
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.